Enveric Biosciences, Inc. research brief
CIK 890821
Generated Nov. 3, 2026, 6:14 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: CAMBRIDGE MA. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.
- May 4, 2026 · D · 0000890821-26-000002 · Source evidence
Reported offering amount: 5000002 USD. Reported amount sold: 5000002 USD.
- Feb. 11, 2026 · D · 0000890821-26-000001 · Source evidence
Reported offering amount: 1450017 USD. Reported amount sold: 1450017 USD.
- Dec. 23, 2025 · D · 0000890821-25-000006 · Source evidence
Reported offering amount: 106598 USD. Reported amount sold: 106598 USD.
- Oct. 3, 2025 · D · 0000890821-25-000004 · Source evidence
Reported offering amount: Unavailable USD. Reported amount sold: 0 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Enveric Biosciences, Inc. research brief,” CIK 890821, retrieved Nov. 3, 2026, 6:14 a.m.. Cite the specific accessions used. No amounts have been summed.